Hehemann Marah C, Raheem Omer A, Rajanahally Saneal, Holt Sarah, Chen Tony, Fustok Judy N, Song Kelly, Rylander Heather, Chow Emma, Ostrowski Kevin A, Muller Charles H, Walsh Thomas J
Department of Urology, University of Washington, Seattle, WA, USA.
Department of Urology, Tulane University Medical Center, 1415 Tulane Avenue, 3rd Floor, New Orleans, LA 70112, USA.
Ther Adv Urol. 2021 Jul 20;13:17562872211032484. doi: 10.1177/17562872211032484. eCollection 2021 Jan-Dec.
To assess if marijuana consumption - prevalent among men of reproductive age and becoming widespread due to decriminalization - is associated with changes in semen parameters. Marijuana's active metabolite, tetrahydrocannabinol, can alter signaling pathways within spermatozoa, affecting spermatogenesis and fertility.
We prospectively evaluated semen analyses (SA) from men presenting for infertility evaluation at one institution from July 2017 to April 2018. Participants completed a reproductive health questionnaire including items regarding marijuana consumption. SA was performed in accordance with World Health Organization (WHO) 5th Edition criteria. SA parameters included volume (ml), concentration (million/ml), motility (%), progressive motility (%), and Tygerberg strict morphology (%).
A total of 409 patients completed the questionnaire; 174 (43%) men reported marijuana use (ever-users). Current and past users comprised 71 (17%) and 103 (25%), respectively. Compared with never-users, current and past users had a significantly higher likelihood of abnormal sperm strict morphology (33.1% 50.7% and 53.4%, respectively; < 0.001). However, sperm motility was more likely to be less than WHO reference values in never-users than current and past-users (38.3% 21.1% and 27.2%, respectively; = 0.01). In multivariate logistic regression analyses, current use was associated with increased odds of abnormal strict morphology [odds ratio (OR) 2.15, 95% confidence interval (CI): 1.21-3.79] and semen volume less than WHO reference value (OR 2.76, 95%CI: 1.19-6.42), while odds of less than WHO reference value sperm motility were reduced (OR 0.47, 95%CI: 0.25-0.91).
Marijuana use is common among men presenting for fertility evaluation, and may have a detrimental effect on semen quality, particularly morphology and volume, but may be protective against abnormal sperm motility. Large, prospective studies of both semen quality and fertility in this growing, at-risk population are warranted.
评估大麻消费——在育龄男性中普遍存在且因合法化而日益广泛——是否与精液参数变化有关。大麻的活性代谢物四氢大麻酚可改变精子内的信号通路,影响精子发生和生育能力。
我们对2017年7月至2018年4月在一家机构进行不育评估的男性的精液分析(SA)进行了前瞻性评估。参与者完成了一份生殖健康问卷,其中包括有关大麻消费的项目。SA按照世界卫生组织(WHO)第5版标准进行。SA参数包括体积(毫升)、浓度(百万/毫升)、活力(%)、前向运动率(%)和泰格堡严格形态学(%)。
共有409名患者完成了问卷;174名(43%)男性报告使用过大麻(曾经使用者)。当前使用者和过去使用者分别为71名(17%)和103名(25%)。与从未使用者相比,当前使用者和过去使用者精子严格形态异常的可能性显著更高(分别为33.1%、50.7%和53.4%;P<0.001)。然而,从未使用者中精子活力低于WHO参考值的可能性高于当前使用者和过去使用者(分别为38.3%、21.1%和27.2%;P=0.01)。在多因素逻辑回归分析中,当前使用与严格形态异常几率增加[比值比(OR)2.15,95%置信区间(CI):1.21-3.79]以及精液体积低于WHO参考值(OR 2.76,95%CI:1.19-6.42)相关,而低于WHO参考值的精子活力几率降低(OR 0.47,95%CI:0.25-0.91)。
大麻使用在进行生育评估的男性中很常见,可能对精液质量有不利影响,尤其是形态和体积,但可能对异常精子活力有保护作用。有必要对这个不断增长的高危人群的精液质量和生育能力进行大规模的前瞻性研究。